Home
>
National Drug Code (NDC)
>
BACTROBAN
BACTROBAN - 0029-1527-22 - (mupirocin calcium)
Drug Information of BACTROBAN
| Product NDC: | 0029-1527 |
| Proprietary Name: | BACTROBAN |
| Non Proprietary Name: | mupirocin calcium |
| Active Ingredient(s): | 21.5 mg/g & nbsp; mupirocin calcium |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of BACTROBAN
| Product NDC: | 0029-1527 |
| Labeler Name: | GlaxoSmithKline LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050746 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19980123 |
Package Information of BACTROBAN
| Package NDC: | 0029-1527-22 |
| Package Description: | 1 TUBE in 1 CARTON (0029-1527-22) > 15 g in 1 TUBE |
NDC Information of BACTROBAN
| NDC Code | 0029-1527-22 |
| Proprietary Name | BACTROBAN |
| Package Description | 1 TUBE in 1 CARTON (0029-1527-22) > 15 g in 1 TUBE |
| Product NDC | 0029-1527 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | mupirocin calcium |
| Dosage Form Name | CREAM |
| Route Name | TOPICAL |
| Start Marketing Date | 19980123 |
| Marketing Category Name | NDA |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | MUPIROCIN CALCIUM |
| Strength Number | 21.5 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | RNA Synthetase Inhibitor Antibacterial [EPC],RNA Synthetase Inhibitors [MoA] |
